STOCK TITAN

[Form 4] METLIFE INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

MetLife, Inc. (MET) non‑management director Carla A. Harris acquired 534 shares of MetLife common stock on 10/01/2025 at a reported price of $81.93 per share. After this transaction the reporting person beneficially owned 9,048 shares. The filing states these shares represent part of director retainer fees that were elected to be deferred under the MetLife Deferred Compensation Plan for Non‑Management Directors. The Form 4 was signed by an attorney‑in‑fact on behalf of the reporting person on 10/03/2025.

MetLife, Inc. (MET) consigliere non esecutivo Carla A. Harris ha acquisito 534 azioni ordinarie di MetLife il 01/10/2025 a un prezzo riportato di $81,93 per azione. Dopo questa operazione la persona segnalante possedeva 9.048 azioni beneficiariamente. La dichiarazione indica che queste azioni rientrano tra una parte dei compensi di amministratore che sono stati eletti per essere differiti ai sensi del MetLife Deferred Compensation Plan for Non‑Management Directors. Il Modulo 4 è stato firmato da un procuratore in fact per conto della persona segnalante il 03/10/2025.

MetLife, Inc. (MET) directora no ejecutiva Carla A. Harris adquirió 534 acciones de MetLife Common stock el 01/10/2025 a un precio reportado de $81.93 por acción. Después de esta operación la persona que reporta poseía 9,048 acciones beneficiosamente. La declaración indica que estas acciones representan parte de las tarifas de retención de director que fueron electas para diferirse bajo el MetLife Deferred Compensation Plan for Non‑Management Directors. El Formulario 4 fue firmado por un apoderado en nombre de la persona que reporta el 03/10/2025.

MetLife, Inc. (MET) 비경영진 이사인 Carla A. Harris534주를 2025-10-01에 MetLife의 보통주로 취득했습니다. 주당 보고 가격은 $81.93였습니다. 이 거래 후 보고자(신고자)는 총 9,048주를 실질적으로 소유하게 되었습니다. 공시에는 이 주식이 비경영진 이사들의 보수 중 일부로, MetLife Deferred Compensation Plan for Non‑Management Directors에 따라 이연되도록 선택되었음을 나타냅니다. Form 4은 2025-10-03에 보고자를 대신하여 대리인(attorney‑in‑fact)이 서명했습니다.

MetLife, Inc. (MET) administrateur non exécutif Carla A. Harris a acquis 534 actions ordinaires de MetLife le 01/10/2025 à un prix déclaré de $81,93 par action. Après cette opération, la personne déclarant détenait 9 048 actions de manière bénéficiaire. Le dossier indique que ces actions représentent une partie des frais de rétention d'administrateur qui ont été éludés pour être différés dans le cadre du MetLife Deferred Compensation Plan for Non‑Management Directors. Le Formulaire 4 a été signé par un puissant représentant en fait au nom de la personne déclarant le 03/10/2025.

MetLife, Inc. (MET) nicht leitender Direktorin Carla A. Harris erwarb 534 MetLife Stammaktien am 01.10.2025 zu einem gemeldeten Preis von $81,93 pro Aktie. Nach dieser Transaktion hielt die meldende Person 9.048 Aktien. Die Einreichung besagt, dass diese Aktien einen Teil der Direktoren-Gehälter darstellen, die gemäß dem MetLife Deferred Compensation Plan for Non‑Management Directors aufgeschoben wurden. Das Formular 4 wurde am 03.10.2025 von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

MetLife, Inc. (MET) المدير غير التنفيذي Carla A. Harris قد اكتسبت 534 سهماً من MetLife العادية في 01/10/2025 بسعر موثق قدره $81.93 للسهم الواحد. بعد هذه الصفقة أصبحت الشخص المبلّغ عنه يملك بشكل مستفيد 9,048 سهماً. تشير الإيداع إلى أن هذه الأسهم تمثل جزءاً من أتعاب الاحتفاظ بالمدير التي اختير تأجيلها بموجب MetLife Deferred Compensation Plan for Non‑Management Directors. تم توقيع النموذج 4 من قبل وكيل نيابة باسم الشخص المبلّغ عنه في 03/10/2025.

MetLife, Inc. (MET) 非管理层董事 Carla A. Harris2025/10/01 以每股 $81.93 的报导价格购买了 534 股 MetLife 普通股。完成此交易后,报告人实际拥有 9,048 股。 filing 表示这些股份代表作为董事报酬的一部分,选择根据 MetLife Deferred Compensation Plan for Non‑Management Directors 延后支付。Form 4 于 2025/10/03 由一名代理律师代表报告人签署。

Positive
  • None.
Negative
  • None.

MetLife, Inc. (MET) consigliere non esecutivo Carla A. Harris ha acquisito 534 azioni ordinarie di MetLife il 01/10/2025 a un prezzo riportato di $81,93 per azione. Dopo questa operazione la persona segnalante possedeva 9.048 azioni beneficiariamente. La dichiarazione indica che queste azioni rientrano tra una parte dei compensi di amministratore che sono stati eletti per essere differiti ai sensi del MetLife Deferred Compensation Plan for Non‑Management Directors. Il Modulo 4 è stato firmato da un procuratore in fact per conto della persona segnalante il 03/10/2025.

MetLife, Inc. (MET) directora no ejecutiva Carla A. Harris adquirió 534 acciones de MetLife Common stock el 01/10/2025 a un precio reportado de $81.93 por acción. Después de esta operación la persona que reporta poseía 9,048 acciones beneficiosamente. La declaración indica que estas acciones representan parte de las tarifas de retención de director que fueron electas para diferirse bajo el MetLife Deferred Compensation Plan for Non‑Management Directors. El Formulario 4 fue firmado por un apoderado en nombre de la persona que reporta el 03/10/2025.

MetLife, Inc. (MET) 비경영진 이사인 Carla A. Harris534주를 2025-10-01에 MetLife의 보통주로 취득했습니다. 주당 보고 가격은 $81.93였습니다. 이 거래 후 보고자(신고자)는 총 9,048주를 실질적으로 소유하게 되었습니다. 공시에는 이 주식이 비경영진 이사들의 보수 중 일부로, MetLife Deferred Compensation Plan for Non‑Management Directors에 따라 이연되도록 선택되었음을 나타냅니다. Form 4은 2025-10-03에 보고자를 대신하여 대리인(attorney‑in‑fact)이 서명했습니다.

MetLife, Inc. (MET) administrateur non exécutif Carla A. Harris a acquis 534 actions ordinaires de MetLife le 01/10/2025 à un prix déclaré de $81,93 par action. Après cette opération, la personne déclarant détenait 9 048 actions de manière bénéficiaire. Le dossier indique que ces actions représentent une partie des frais de rétention d'administrateur qui ont été éludés pour être différés dans le cadre du MetLife Deferred Compensation Plan for Non‑Management Directors. Le Formulaire 4 a été signé par un puissant représentant en fait au nom de la personne déclarant le 03/10/2025.

MetLife, Inc. (MET) nicht leitender Direktorin Carla A. Harris erwarb 534 MetLife Stammaktien am 01.10.2025 zu einem gemeldeten Preis von $81,93 pro Aktie. Nach dieser Transaktion hielt die meldende Person 9.048 Aktien. Die Einreichung besagt, dass diese Aktien einen Teil der Direktoren-Gehälter darstellen, die gemäß dem MetLife Deferred Compensation Plan for Non‑Management Directors aufgeschoben wurden. Das Formular 4 wurde am 03.10.2025 von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Harris Carla A

(Last) (First) (Middle)
METLIFE, INC.
200 PARK AVENUE

(Street)
NEW YORK NY 10166

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A(1) 534 A $81.93 9,048 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
Remarks:
/s/ Taylor McInerney Jansen, Attorney-in-fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MetLife director Carla A. Harris report on Form 4 (MET)?

The Form 4 reports the acquisition of 534 shares on 10/01/2025 at $81.93 per share and beneficial ownership of 9,048 shares after the transaction.

Why were the shares acquired by the director?

The filing states the shares represent part of non‑management director retainer fees that the director elected to defer under the MetLife Deferred Compensation Plan for Non‑Management Directors.

How was the Form 4 signed and when?

The Form 4 was signed by an attorney‑in‑fact, Taylor McInerney Jansen, on behalf of the reporting person on 10/03/2025.

What is the reporting person's relationship to MetLife?

The reporting person, Carla A. Harris, is listed as a Director and the Form is filed by one reporting person.

How many shares did the reporting person own after the transaction?

Following the reported transaction the reporting person beneficially owned 9,048 shares.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

54.09B
663.27M
0.25%
91.63%
1.37%
Insurance - Life
Life Insurance
Link
United States
NEW YORK